Bright Minds Biosciences (DRUG) Share-based Compensation (2020 - 2026)
Bright Minds Biosciences (DRUG) recorded Share-based Compensation of $1.12 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 17.4% from $953,651 a year earlier and up 27.4% from the prior quarter.
Bright Minds Biosciences (DRUG) Share-based Compensation (2020 - 2026) Analysis & Trends
On a TTM basis, Bright Minds Biosciences' Share-based Compensation came in at $3.7 million as of Jun 30, 2026, up 122.3% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $2.28 million, up 268.8% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of 80.2% (FY2020 to FY2025).
- Across earlier fiscal years, Share-based Compensation came in at $617,402 in FY2024 (-27.7%), $854,523 in FY2023 (+24.7%), $685,450 in FY2022 (-1.6%) and $696,772 in FY2021 (+480.6%).
- The fiscal Q3 2026 figure is the highest quarterly Share-based Compensation in data going back to fiscal Q1 2021.
- On a year-over-year basis, Share-based Compensation has increased for six consecutive quarters, with growth averaging 231.3% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 659.1% in fiscal Q2 2024, against a decline of 92.3% in fiscal Q4 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $878,672 (Q2 2026), $921,593 (Q1 2026) and $776,796 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Bright Minds Biosciences | 343.90 Mn | -219.69 Mn | - | 1.12 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 878,672.44 |
| Dec 31, 2025 | 921,592.84 |
| Sep 30, 2025 | 776,796.07 |
| Jun 30, 2025 | 953,650.69 |
| Mar 31, 2025 | 429,236.43 |
| Dec 31, 2024 | 126,269.35 |
| Sep 30, 2024 | 154,116.42 |
| Jun 30, 2024 | 134,486.72 |
| Mar 31, 2024 | 168,194.02 |
| Dec 31, 2023 | 160,825.82 |
| Sep 30, 2023 | 298,742.92 |
| Jun 30, 2023 | 176,833.52 |
| Mar 31, 2023 | 22,158.34 |
| Dec 31, 2022 | 356,669.57 |
| Sep 30, 2022 | 22,937.21 |
| Jun 30, 2022 | 230,109.86 |
| Mar 31, 2022 | 229,607.08 |
| Dec 31, 2021 | 207,002.01 |
| Sep 30, 2021 | 299,146.74 |
Bright Minds Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();